These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


365 related items for PubMed ID: 14657683

  • 1. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS.
    Transplantation; 2003 Nov 27; 76(10):1444-7. PubMed ID: 14657683
    [Abstract] [Full Text] [Related]

  • 2. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 3. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J.
    Transplantation; 2009 Jan 27; 87(2):268-73. PubMed ID: 19155983
    [Abstract] [Full Text] [Related]

  • 4. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M, Tagnaouti M, Audard V, Dahan K, Lang P, Grimbert P.
    Transplant Proc; 2007 Oct 27; 39(8):2565-7. PubMed ID: 17954175
    [Abstract] [Full Text] [Related]

  • 5. Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.
    Kute VB, Vanikar AV, Trivedi HL, Shah PR, Goplani KR, Patel HV, Gumber MR, Patel RD, Kanodia KV, Suthar KS, Trivedi VB, Modi PR.
    Saudi J Kidney Dis Transpl; 2011 Jul 27; 22(4):662-9. PubMed ID: 21743208
    [Abstract] [Full Text] [Related]

  • 6. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity.
    Scornik JC, Brunson ME, Schaub B, Howard RJ, Pfaff WW.
    Transplantation; 1994 Feb 27; 57(4):621-5. PubMed ID: 8116050
    [Abstract] [Full Text] [Related]

  • 7. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S, Kitada H, Okabe Y, Kawanami S, Noguchi H, Miyamoto K, Tsuchimoto A, Masutani K, Tanaka M.
    Exp Clin Transplant; 2014 Jun 27; 12(3):227-32. PubMed ID: 24907723
    [Abstract] [Full Text] [Related]

  • 8. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
    Magee CC, Felgueiras J, Tinckam K, Malek S, Mah H, Tullius S.
    Transplantation; 2008 Jul 15; 86(1):96-103. PubMed ID: 18622284
    [Abstract] [Full Text] [Related]

  • 9. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP, Wang CX, Gao W, Fu Q, He XS.
    Exp Clin Transplant; 2010 Jun 15; 8(2):130-5. PubMed ID: 20565369
    [Abstract] [Full Text] [Related]

  • 10. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 15; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R.
    Transplantation; 1995 Nov 15; 60(9):1016-23. PubMed ID: 7491675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 18. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB, Lublin DM, Phelan DL, Boslaugh SE, Gandhi SK, Huddleston CB, Saffitz JE, Canter CE.
    J Heart Lung Transplant; 2007 Sep 20; 26(9):876-82. PubMed ID: 17845925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ, Kerman RH, Podder H, Katz SM, Van Buren CT, Kahan BD.
    Transplant Proc; 2005 Mar 20; 37(2):1280-2. PubMed ID: 15848695
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.